Ahn-Gook Pharmaceutical Co., Ltd. (KOSDAQ:001540)
South Korea flag South Korea · Delayed Price · Currency is KRW
7,760.00
+110.00 (1.44%)
At close: May 30, 2025, 3:30 PM KST

Ahn-Gook Pharmaceutical Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Operating Revenue
281,128271,116233,676205,389163,534143,364
Upgrade
Other Revenue
-0---0--
Upgrade
Revenue
281,128271,116233,676205,389163,534143,364
Upgrade
Revenue Growth (YoY)
15.11%16.02%13.77%25.59%14.07%-8.01%
Upgrade
Cost of Revenue
104,106103,21993,10579,10962,51658,471
Upgrade
Gross Profit
177,022167,896140,571126,279101,01884,893
Upgrade
Selling, General & Admin
149,556145,430121,343102,05283,15764,021
Upgrade
Research & Development
14,93613,25912,25512,95717,32816,993
Upgrade
Operating Expenses
167,552161,219135,509116,899102,10284,942
Upgrade
Operating Income
9,4706,6785,0619,381-1,084-49.1
Upgrade
Interest Expense
-3,211-3,002-142.75-160.41-116.83-756.89
Upgrade
Interest & Investment Income
412.58463.68388.54407.43335.82971.68
Upgrade
Earnings From Equity Investments
-4,7801,352-1,641-1,6452,6131,780
Upgrade
Currency Exchange Gain (Loss)
35.368.82-79.74-82.27133.07-302.34
Upgrade
Other Non Operating Income (Expenses)
-467.551,453-258.15336.26-246.68-1,431
Upgrade
EBT Excluding Unusual Items
1,4607,0133,3288,2371,634212.8
Upgrade
Gain (Loss) on Sale of Investments
385.87230.47921.68-889.552,033625.7
Upgrade
Gain (Loss) on Sale of Assets
13,23613,21617.1328.25138.65-60.42
Upgrade
Asset Writedown
-219.98-219.98----
Upgrade
Pretax Income
14,86220,2394,2677,3753,805778.08
Upgrade
Income Tax Expense
2,7013,8963,269496.1461.492,166
Upgrade
Earnings From Continuing Operations
12,16116,343998.286,8793,744-1,388
Upgrade
Net Income to Company
12,16116,343998.286,8793,744-1,388
Upgrade
Minority Interest in Earnings
470.98502.28291.85-3.95195.5672.98
Upgrade
Net Income
12,63216,8451,2906,8753,939-1,315
Upgrade
Net Income to Common
12,63216,8451,2906,8753,939-1,315
Upgrade
Net Income Growth
97.19%1205.72%-81.24%74.54%--
Upgrade
Shares Outstanding (Basic)
111111111111
Upgrade
Shares Outstanding (Diluted)
111111111113
Upgrade
Shares Change (YoY)
0.02%--0.12%-0.65%-9.44%10.37%
Upgrade
EPS (Basic)
1111.111482.18113.51604.21343.93-114.79
Upgrade
EPS (Diluted)
1110.941482.00113.51604.00343.93-114.79
Upgrade
EPS Growth
97.12%1205.57%-81.21%75.62%--
Upgrade
Free Cash Flow
8,789-70,972-6,802-1,143-2,563-12,929
Upgrade
Free Cash Flow Per Share
773.05-6244.63-598.47-100.42-223.77-1022.23
Upgrade
Dividend Per Share
440.000440.000----
Upgrade
Gross Margin
62.97%61.93%60.16%61.48%61.77%59.21%
Upgrade
Operating Margin
3.37%2.46%2.17%4.57%-0.66%-0.03%
Upgrade
Profit Margin
4.49%6.21%0.55%3.35%2.41%-0.92%
Upgrade
Free Cash Flow Margin
3.13%-26.18%-2.91%-0.56%-1.57%-9.02%
Upgrade
EBITDA
18,02914,37610,08414,3113,4234,634
Upgrade
EBITDA Margin
6.41%5.30%4.32%6.97%2.09%3.23%
Upgrade
D&A For EBITDA
8,5597,6985,0234,9304,5074,683
Upgrade
EBIT
9,4706,6785,0619,381-1,084-49.1
Upgrade
EBIT Margin
3.37%2.46%2.17%4.57%-0.66%-0.03%
Upgrade
Effective Tax Rate
18.18%19.25%76.61%6.73%1.62%278.43%
Upgrade
Advertising Expenses
-11,3375,5435,7765,4823,935
Upgrade
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.